戻る
「早戻しボタン」を押すと検索画面に戻ります。

今後説明を表示しない

[OK]

コーパス検索結果 (1語後でソート)

通し番号をクリックするとPubMedの該当ページを表示します
1              Critically ill adults requiring continuous renal replacement therapy.
2 r blood flow rate influences circuit life in continuous renal replacement therapy.
3 n of regional citrate anticoagulation during continuous renal replacement therapy.
4 ensity score for the likelihood of receiving continuous renal replacement therapy.
5 blood flow rates of 250 or 150 mL/min during continuous renal replacement therapy.
6 s parameters and then compared with forms of continuous renal replacement therapy.
7 ng adults with acute kidney injury receiving continuous renal replacement therapy.
8                                              Continuous renal replacement therapy.
9 ation of excess fluid that can be removed by continuous renal replacement therapy.
10 atment sessions may use hemodialysis (1D) or continuous renal replacement therapy (1D).
11 ive mechanical ventilation; 5 (19%) received continuous renal-replacement therapy; 22 (81%) received
12                 Of the children managed with continuous renal replacement therapy, 26 (58%) survived:
13 n anticoagulation has remained a problem for continuous renal replacement therapies and intermittent
14 ations existed between effluent flow rate in continuous renal replacement therapy and extracorporeal
15                         We report the use of continuous renal replacement therapy and rituximab in a
16 e to describe feeding practices in pediatric continuous renal replacement therapy and to evaluate fac
17 ntilation, pulmonary artery catheterization, continuous renal replacement therapy, and permanent card
18                  Patients receiving regional continuous renal replacement therapy anticoagulation wit
19 gistry suggests that early intervention with continuous renal replacement therapy, as well as goal-di
20                                              Continuous renal replacement therapy can be used success
21 citrate and calcium anticoagulation prolongs continuous renal replacement therapy circuit life compar
22 mized 212 subjects who were treated with 857 continuous renal replacement therapy circuits (median 2
23                      Based on four groups of continuous renal replacement therapy commencement ([grou
24 time between RIFLE-I acute kidney injury and continuous renal replacement therapy commencement was 17
25 d Level Replacement Therapy Study (proxy for continuous renal replacement therapy commencement) was t
26                                              Continuous renal replacement therapies (CRRT) often are
27                                              Continuous renal replacement therapy (CRRT) benefits pat
28                                              Continuous renal replacement therapy (CRRT) has become a
29                                         Once continuous renal replacement therapy (CRRT) is initiated
30                                              Continuous renal replacement therapy (CRRT) is the most
31                                              Continuous renal replacement therapy (CRRT) machines are
32 patients with ARF compared with conventional continuous renal replacement therapy (CRRT), a Phase II,
33                                           By continuous renal replacement therapy day 5, median prote
34              The degree of fluid overload at continuous renal replacement therapy discontinuation is
35                     Median fluid overload at continuous renal replacement therapy discontinuation was
36  of illness, the change in fluid overload at continuous renal replacement therapy discontinuation was
37 inary results to indicate the earlier use of continuous renal replacement therapy for both renal dysf
38 oreal life support and patients initiated on continuous renal replacement therapy for indications oth
39                        Children who received continuous renal replacement therapy for management of a
40                             Time to initiate continuous renal replacement therapy from PICU admission
41        Although much of the outcome data for continuous renal replacement therapy has been retrospect
42 ith intermittent hemodialysis, initiation of continuous renal replacement therapy in critically ill a
43 verload frequently necessitate initiation of continuous renal replacement therapy in critically ill p
44                           The guidelines for continuous renal replacement therapy in pediatric acute
45                                   The use of continuous renal replacement therapy in pediatric critic
46 ngs suggest a role for earlier initiation of continuous renal replacement therapy in this population,
47 on, extracorporeal membrane oxygenation, and continuous renal replacement therapy, in addition to pla
48 ate an association between fluid overload at continuous renal replacement therapy initiation and mort
49 , severity of illness, and fluid overload at continuous renal replacement therapy initiation found th
50     In pediatric patients, fluid overload at continuous renal replacement therapy initiation is assoc
51                     Median fluid overload at continuous renal replacement therapy initiation was sign
52 rapy initiation found that fluid overload at continuous renal replacement therapy initiation was the
53    Mean protein and caloric prescriptions at continuous renal replacement therapy initiation were 1.3
54 fter adjusting for percent fluid overload at continuous renal replacement therapy initiation, age, an
55 ze the association between fluid overload at continuous renal replacement therapy initiation, fluid r
56               Fluid overload, indication for continuous renal replacement therapy initiation, severit
57 hronologically as time from ICU admission to continuous renal replacement therapy initiation.
58  of such children who may benefit from early continuous renal replacement therapy initiation.
59 he possible relevance of biocompatibility in continuous renal replacement therapies is emphasized.
60                                              Continuous renal replacement therapy is valuable for sur
61  in practice to initiate early and high-dose continuous renal replacement therapy led to increased su
62 emodialysis is preferred initially (1D), but continuous renal replacement therapies may be considered
63            Protein prescription in pediatric continuous renal replacement therapy may be inadequate.
64 onferring greater hemodynamic stability; yet continuous renal replacement therapy may not enhance pat
65 with conventional intermittent hemodialysis, continuous renal replacement therapy may promote kidney
66 this time, center-based results suggest that continuous renal replacement therapy may prove beneficia
67    In patients with sepsis and septic shock, continuous renal replacement therapy offers a means for
68 ermine the effect of timing of initiation of continuous renal replacement therapy on ICU mortality in
69                                 We performed continuous renal replacement therapy on patients.
70 cular access type, length, site, and mode of continuous renal replacement therapy or international no
71  inclusion criteria and 45 of these received continuous renal replacement therapy prior to transplant
72                          We identified 2,315 continuous renal replacement therapy recipients of whom
73                                              Continuous renal replacement therapy recipients were mat
74 r, early data from the prospective pediatric continuous renal replacement therapy registry suggests t
75 ement Therapy Study, earlier commencement of continuous renal replacement therapy relative to RIFLE-I
76  optimal regimen of intermittent dialysis or continuous renal replacement therapy remains to be deter
77                                              Continuous renal replacement therapy should be considere
78 o did not receive a liver transplant, use of continuous renal replacement therapy significantly impro
79  hyperammonemia by 48 hours after initiating continuous renal replacement therapy significantly impro
80  and 189.3 and 35.6 mL/min, respectively, in continuous renal replacement therapy studies.
81 eplacement therapies including hemodialysis, continuous renal replacement therapy, the bioartificial
82 ent therapy initiation, fluid removal during continuous renal replacement therapy, the kinetics of fl
83  was determined to be similar or higher than continuous renal replacement therapy therapies.
84 en patients on the basis of the intensity of continuous renal replacement therapy; this effect may ha
85 otein and caloric prescription and number of continuous renal replacement therapy treatment days (p <
86 ine whether bacteria could be recovered from continuous renal replacement therapy ultrafiltrates of c
87 rms of length of stay, ventilator usage, and continuous renal replacement therapy usage compared with
88                                              Continuous renal replacement therapy usage, defined as p
89                                              Continuous renal replacement therapy using blood flow ra
90                           Initial receipt of continuous renal replacement therapy versus intermittent
91  lower among patients who initially received continuous renal replacement therapy versus intermittent
92                        Earlier initiation of continuous renal replacement therapy was associated with
93       Our objective was to determine whether continuous renal replacement therapy was associated with
94 up 4]: >/= 46.0 hr), earlier commencement of continuous renal replacement therapy was not associated
95         In critically ill patients receiving continuous renal replacement therapy, we aimed to assess
96 with severe acute kidney injury treated with continuous renal replacement therapy, we found no associ
97 mal protein and caloric prescriptions during continuous renal replacement therapy were 2.0 +/- 1.5 g/
98 al protein and caloric prescription while on continuous renal replacement therapy were younger age, i
99 rations in critically ill patients receiving continuous renal replacement therapy, which did not only
100 ty in a large pediatric population receiving continuous renal replacement therapy while on extracorpo
101                                              Continuous renal replacement therapy without anticoagula

WebLSDに未収録の専門用語(用法)は "新規対訳" から投稿できます。
 
Page Top